GeneDx Holdings Corp.
WGS
$56.33
$4.538.75%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -258.41% | -131.38% | -170.64% | 265.55% | -220.06% |
| Total Depreciation and Amortization | 13.84% | -7.62% | 4.57% | 9.03% | 21.90% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 467.15% | -57.91% | 102.88% | 27.04% | 239.22% |
| Change in Net Operating Assets | -8,940.46% | 109.13% | 82.43% | -587.59% | 143.18% |
| Cash from Operations | -948.80% | -119.60% | 51.31% | 2.34% | 419.89% |
| Capital Expenditure | -48.45% | 29.57% | -160.53% | 61.35% | -100.95% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | 100.00% | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -52.92% | -575.69% | 288.93% | 76.03% | -229.55% |
| Cash from Investing | -55.84% | -136.23% | 87.11% | -286.37% | -1,712.72% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -8,542.52% | 43.91% | -42.56% | 6.37% | 40.38% |
| Issuance of Common Stock | -97.76% | 99.22% | 899.50% | 63.13% | -97.74% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 66.39% | 115.39% | 3,012.14% | -97.48% | -55.78% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -222.61% | -58.66% | 185.40% | -276.54% | -46.96% |